183 related articles for article (PubMed ID: 1826426)
1. Enhanced CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus.
Stekman IL; Blasini AM; Leon-Ponte M; Baroja ML; Abadi I; Rodriguez MA
Arthritis Rheum; 1991 Apr; 34(4):459-67. PubMed ID: 1826426
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities in CD69 expression, cytosolic pH and Ca2+ during activation of lymphocytes from patients with systemic lupus erythematosus.
Portales-Pérez D; González-Amaro R; Abud-Mendoza C; Sánchez-Armáss S
Lupus; 1997; 6(1):48-56. PubMed ID: 9116719
[TBL] [Abstract][Full Text] [Related]
3. Activation of cord T lymphocytes. II. Cellular and molecular analysis of the defective response induced by anti-CD3 monoclonal antibody.
Bertotto A; Gerli R; Lanfrancone L; Crupi S; Arcangeli C; Cernetti C; Spinozzi F; Rambotti P
Cell Immunol; 1990 May; 127(2):247-59. PubMed ID: 2139363
[TBL] [Abstract][Full Text] [Related]
4. T lymphocytes from patients with systemic lupus erythematosus show increased response to interleukin-2 after costimulation with OKT3 monoclonal antibody and phorbol esters.
Blasini AM; Stekman IL; Gonzalez F; Tositti ML; Rodriguez MA
Clin Immunol Immunopathol; 1994 Jan; 70(1):66-72. PubMed ID: 8261671
[TBL] [Abstract][Full Text] [Related]
5. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
Hess AD; Bright EC
Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
[TBL] [Abstract][Full Text] [Related]
7. [The classical and alternative pathways of T-lymphocyte activation in patients with systemic lupus erythematosus].
Stanislav ML; Balabanova RM; Nikonova MF; Litvina MM; Iarilin AA
Ter Arkh; 1999; 71(5):30-4. PubMed ID: 10399227
[TBL] [Abstract][Full Text] [Related]
8. B7/BB1 provides an important costimulatory signal for CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus (SLE).
Sfikakis PP; Oglesby R; Sfikakis P; Tsokos GC
Clin Exp Immunol; 1994 Apr; 96(1):8-14. PubMed ID: 7512010
[TBL] [Abstract][Full Text] [Related]
9. Responsiveness of systemic lupus erythematosus T cells to signals provided through LCA T200 (CD45) and T1 (CD5) antigens.
Martorell J; Font J; Rojo I; Vilella R; Ingelmo M; Vives J
Clin Exp Immunol; 1989 Nov; 78(2):172-6. PubMed ID: 12412744
[TBL] [Abstract][Full Text] [Related]
10. Defective CD2 pathway T cell activation in systemic lupus erythematosus.
Fox DA; Millard JA; Treisman J; Zeldes W; Bergman A; Depper J; Dunne R; McCune WJ
Arthritis Rheum; 1991 May; 34(5):561-71. PubMed ID: 1673843
[TBL] [Abstract][Full Text] [Related]
11. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
Wacholtz MC; Patel SS; Lipsky PE
J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
[TBL] [Abstract][Full Text] [Related]
12. Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: variable dependence on interleukin-1 as a helper signal for T-cell activation.
Verwilghen J; Baroja ML; Van Vaeck F; Van Damme J; Ceuppens JL
Immunology; 1991 Feb; 72(2):269-76. PubMed ID: 1826671
[TBL] [Abstract][Full Text] [Related]
13. Responsiveness of T lymphocytes from systemic lupus erythematosus to signals provided through CD26 antigen.
Plana M; Font J; Viñas O; Martorell J; Ingelmo M; Vives J
Clin Immunol Immunopathol; 1994 Aug; 72(2):227-32. PubMed ID: 7914157
[TBL] [Abstract][Full Text] [Related]
14. Activation markers on peripheral blood T cells from patients with active or inactive systemic lupus erythematosus. Correlation with proliferative responses and production of IL-2.
Alcocer-Varela J; Alarcón-Riquelme M; Laffón A; Sánchez-Madrid F; Alarcón-Segovia D
J Autoimmun; 1991 Dec; 4(6):935-45. PubMed ID: 1812897
[TBL] [Abstract][Full Text] [Related]
15. CD3-induced T-cell proliferation and interleukin-2 secretion is modulated by the CD45 antigen.
Oravecz T; Monostori E; Kurucz E; Takács L; Andó I
Scand J Immunol; 1991 Nov; 34(5):531-7. PubMed ID: 1835124
[TBL] [Abstract][Full Text] [Related]
16. [CD2-mediated T-lymphocyte proliferation in patients with systemic lupus erythematosus].
Tang FL
Zhonghua Yi Xue Za Zhi; 1993 Nov; 73(11):661-3, 701. PubMed ID: 7907269
[TBL] [Abstract][Full Text] [Related]
17. Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus.
Tsai HF; Lai JJ; Chou AH; Wang TF; Wu CS; Hsu PN
Arthritis Rheum; 2004 Feb; 50(2):629-39. PubMed ID: 14872508
[TBL] [Abstract][Full Text] [Related]
18. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
19. Impaired T-cell activation in patients with systemic lupus erythematosus.
Sierakowski S; Kucharz EJ; Lightfoot RW; Goodwin JS
J Clin Immunol; 1989 Nov; 9(6):469-76. PubMed ID: 2517125
[TBL] [Abstract][Full Text] [Related]
20. Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation.
Jullien P; Cron RQ; Dabbagh K; Cleary A; Chen L; Tran P; Stepick-Biek P; Lewis DB
Int Immunol; 2003 Dec; 15(12):1461-72. PubMed ID: 14645155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
